FDA Warns Guangdong for API Label Mix-Up

Nov 09, 2017


The U.S. FDA issued a warning letter to China-based Guangdong Zhanjiang Jimin Pharmaceutical Co. after finding that one of the company’s over-the-counter drugs had a label listing an incorrect active pharmaceutical ingredient.

According to the label on Guangdong’s Piyanping Anti-Itch Lotion, the product contains hydrocortisone 1% as its active ingredient, when in fact, the active ingredient is dexamethasone acetate.

The manufacturer told the FDA that the labelling issue was the result of "a translation mistake.”

Read the RAPS coverage

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments